Multimeric Gets Innovation Grant

Xconomy San Diego — 

The National Institute on Drug Abuse has awarded an innovation grant worth $350,000 over two years to San Diego’s Multimeric Biotherapeutics to develop a vaccine against nicotine, and eventually other drugs of abuse. Multimeric says vaccines against nicotine are designed to generate antibodies that sequester nicotine in the blood and prevent the molecules from crossing into the brain and re-enforcing the nicotine habit. As I reported in October, the two-year-old biotech is developing proprietary methods for boosting highly targeted antibody responses.